Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia

Experimental Hematology

Volumn 36, Issue 9, 2008, Pages 1078-1083

  Subbiah, Vivek ^a,d   Viny, Aaron D ^a,c   Rosenblatt, Steven ^a   Pohlman, Brad ^a,b   Lichtin, Alan ^a,b   Maciejewski, Jaroslaw P ^a,b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CYTOPENIA; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE REARRANGEMENT; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOPHENOTYPING; LARGE GRANULAR LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PANCYTOPENIA; PRIORITY JOURNAL; SPLEEN WEIGHT; SPLENECTOMY; SPLENOMEGALY; SURGICAL MORTALITY; T CELL LEUKEMIA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CELL COUNT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PANCYTOPENIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SPLENECTOMY; SPLENOMEGALY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 49349113615     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.04.005     Document Type: Article

References (36)

1. Kanchan K., and Loughran Jr. T.P. Antigen-driven clonal T cell expansion in disorders of hematopoiesis. Leuk Res 27 (2003) 291-292
2. Lamy T., and Loughran Jr. T.P. Clinical features of large granular lymphocyte leukemia. Semin Hematol 40 (2003) 185-195
3. Wlodarski M.W., Schade A.E., and Maciejewski J.P. T-large granular lymphocyte leukemia: current molecular concepts. Hematology 11 (2006) 245-256
4. Lazaro E., Caubet O., Menard F., Pellegrin J.L., and Viallard J.F. Large granular lymphocyte leukemia. Presse Med 36 (2007) 1694-1700
5. Dhodapkar M.V., Li C.Y., Lust J.A., Tefferi A., and Phyliky R.L. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 84 (1994) 1620-1627
6. Sabnani I., and Tsang P. Are clonal T-cell large granular lymphocytes to blame for unexplained haematological abnormalities?. Br J Haematol 136 (2007) 30-37
7. Semenzato G., Zambello R., Starkebaum G., Oshimi K., and Loughran Jr. T.P. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89 (1997) 256-260
8. Lima M., Almeida J., Santos A.H., et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 159 (2001) 186-11868
9. Lamy T., and Loughran Jr. T.P. Current concepts: large granular lymphocyte leukemia. Blood Rev 13 (1999) 230-240
10. Melenhorst J.J., Eniafe R., Follmann D., et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J 4 (2003) 18-25
11. Alekshun T.J., and Sokol L. Diseases of large granular lymphocytes. Cancer Control 14 (2007) 141-150
12. O'Malley D.P. T-cell large granular leukemia and related proliferations. Am J Clin Pathol 127 (2007) 850-859
13. Loughran Jr. T.P., Starkebaum G., Clark E., Wallace P., and Kadin M.E. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 67 (1987) 135-140
14. Lanzi S., Lancini G.P., Piardi T., et al. Splenectomy in immune thrombocytopenia and other hematological diseases. G Chir 20 (1999) 479-486
15. Font J., Jimenez S., Cervera R., et al. Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. Ann Rheum Dis 59 (2000) 920-923
16. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 (2002) 995-1008
17. Bromberg M.E. Immune thrombocytopenic purpura-the changing therapeutic landscape. N Engl J Med 355 (2006) 1643-1645
18. Vevon P.A., Ellison E.C., and Carey L.C. Splenectomy for hematologic disease. Adv Surg 22 (1989) 105-139
19. Seymour J.F., Cusack J.D., Lerner S.A., Pollock R.E., and Keating M.J. Case/control study of the role of splenectomy in chronic lymphocytic leukemia. J Clin Oncol 15 (1997) 52-60
20. Bouvet M., Babiera G.V., Termuhlen P.M., Hester J.P., Kantarjian H.M., and Pollock R.E. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience. Surgery 122 (1997) 20-25
21. Berman R.S., Feig B.W., Hunt K.K., Mansfield P.F., and Pollock R.E. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy. Ann Surg 240 (2004) 852-857
22. Burks E.J., and Loughran Jr. T.P. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 20 (2006) 245-266
23. Rashba E.J., Rowe J.M., and Packman C.H. Treatment of the neutropenia of Felty syndrome. Blood Rev 10 (1996) 177-184
24. Berliner N., Duby A.D., Linch D.C., et al. T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood 67 (1986) 914-918
25. Herling M., Khoury J.D., Washington L.T., Duvic M., Keating M.J., and Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104 (2004) 328-335
26. Wlodarski M.W., O'Keefe C., Howe E.C., et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 106 (2005) 2769-2780
27. Nearman Z.P., Wlodarski M., Jankowska A.M., et al. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol 136 (2007) 237-248
28. Viny Ad Lichtin.A., Pohlman B., Loughran T.P., and Maciejewski J.P. Chronic B-cell dyscrasias are an important clinical feature of LGL leukemia. Leuk Lymphoma 49 (2008) 932-938
29. Sokol L., and Loughran Jr. T.P. Large granular lymphocyte leukemia. Oncologist 11 (2006) 263-273
30. Osuji N., Matutes E., Tjonnfjord G., et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer 107 (2006) 570-578
31. Sood R., Stewart C.C., Aplan P.D., et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 91 (1998) 3372-3378
32. Furukawa Y., Tanaka K., Hasuike T., et al. Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+. Rinsho Byori 39 (1991) 557-561
33. Gentile T.C., and Loughran Jr. T.P. Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia. Leuk Lymphoma 23 (1996) 405-408
34. Brinkman K., van Dongen J.J., van Lom K., Groeneveld K., Misere J.F., and van der Heul C. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies. Leukemia 12 (1998) 150-154
35. Nowakowski G.S., Morice W.G., Phyliky R.L., Li C.Y., and Tefferi A. Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol 128 (2005) 490-492
36. Coad J.E., Matutes E., and Catovsky D. Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature. Leuk Lymphoma 10 (1993) 245-264